ACR 3.13% 6.2¢ acrux limited

FDA questions efficacy of testosterone and whether risks really do exist, page-2

  1. 128 Posts.
    lightbulb Created with Sketch. 2
    Personally, I think this is good rather then bad news as all those concerns of heart attacks and strokes all but disappear, Acrux continues to get their product approved in more countries, and testosterone remains a valid treatment of a fairly large proportion of the population. So in short, this product is not going to disappear quite the contrary!
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
-0.002(3.13%)
Mkt cap ! $18.02M
Open High Low Value Volume
6.4¢ 6.4¢ 6.2¢ $19.56K 306.8K

Buyers (Bids)

No. Vol. Price($)
3 165056 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 63158 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.